- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04733872
Using Vegetable and Berry Products Can Improve Skin Conditions
February 1, 2021 updated by: TCI Co., Ltd.
Hypothesis: vegetable and berry products for 8 weeks can improve skin condition
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Hypothesis: Using vegetable and berry products for 8 weeks can improve skin condition
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Neipu Township
-
Taipei, Neipu Township, Taiwan, 100225
- Research & Design Center, TCI CO., Ltd
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Dry skin
- Rough skin
- Large pores
- Dark yellow complexion
- Sagging skin
Exclusion Criteria:
- Skin disorders
- Liver diseases
- Kidney diseases
- Allergy to cosmetics, drugs, or foods
- Pregnant and lactating women
- People who had any cosmetic procedures before 4 weeks of the study
- Area of facial spot over 3 cm2
- Vegan
- People who took collagen supplements in the past 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: placebo group
subjects drank 50 ml , 1 bottle a day for 8 week
|
subjects drank 50 ml , 1 bottle a day for 8 week
|
Experimental: Vegetable and Berry Drink
subjects drank 50 ml , 1 bottle a day for 8 week
|
subjects drank 50 ml , 1 bottle a day for 8 week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
skin elasticity
Time Frame: up to 8 week
|
using cutometer dual MPA580 to examine skin elasticity (The closer the R2 value is to 1, the better the elasticity and no unit)
|
up to 8 week
|
skin gloss
Time Frame: up to 8 week
|
using probe system GL2000 & MPA10 to examine skin gloss (The higher the value, the higher the gloss, no unit)
|
up to 8 week
|
skin spot
Time Frame: up to 8 week
|
usig VISIA-CR to examine skin spot (The higher the value, the larger the pore area, mm2)
|
up to 8 week
|
skin wrinkle
Time Frame: up to 8 week
|
using VISIOSCAN-VC20 to examine skin wrinkle (The higher the value, the more wrinkles, surface evaluation of wrinkles, SEW)
|
up to 8 week
|
skin moisture
Time Frame: up to 8 week
|
using corneometer CM825 to examine skin moisture (The higher the value, the more water content, C.U., corneometer units ).subjects drank 50 ml after meal
|
up to 8 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2017
Primary Completion (Actual)
July 31, 2018
Study Completion (Actual)
October 31, 2018
Study Registration Dates
First Submitted
January 26, 2021
First Submitted That Met QC Criteria
February 1, 2021
First Posted (Actual)
February 2, 2021
Study Record Updates
Last Update Posted (Actual)
February 2, 2021
Last Update Submitted That Met QC Criteria
February 1, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20180905VAB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Condition
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedPrecancerous/Nonmalignant ConditionUnited States
-
AI Labs Group S.LOsakidetza; Hospital Universitario Cruces; Servicio Vasco de Salud Osakidetza...RecruitingSkin Diseases | Skin ConditionSpain
-
TCI Co., Ltd.Recruiting
-
TCI Co., Ltd.Completed
-
TCI Co., Ltd.Active, not recruiting
-
TCI Co., Ltd.Completed
-
TCI Co., Ltd.Completed
Clinical Trials on placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States